spironolactone has been researched along with cyproterone acetate in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (24.44) | 18.7374 |
1990's | 17 (18.89) | 18.2507 |
2000's | 26 (28.89) | 29.6817 |
2010's | 23 (25.56) | 24.3611 |
2020's | 2 (2.22) | 2.80 |
Authors | Studies |
---|---|
Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ali, A; Bassaw, B; Maharaj, R; Roopnarinesingh, S | 1 |
Schindler, AE | 1 |
Cooper, ME; Jerums, G; Murray, RM; O'Brien, RC; Seeman, E; Thomas, AK | 1 |
Concolino, G; Di Silverio, F; Sciarra, F; Toscano, V | 1 |
Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
Namer, M | 1 |
Pugeat, M | 1 |
Mowszowicz, I | 1 |
Cooper, M; Jerums, G; Montalto, J; Slobodniuk, R; Taft, J; Thomas, AK | 1 |
Schmidt, JB | 1 |
Bouchard, P; Silvestre, L | 1 |
Fair, WR; Sogani, PC | 1 |
Verschoore, M | 1 |
Biffignandi, P; Molinatti, GM | 1 |
Hauffa, BP; Havers, W; Stolecke, H | 1 |
Bowden, J; Frank, BL; Frost, P; Horwitz, SN; Weissmann, A | 1 |
Djøseland, O; Lunde, O | 1 |
Biffignandi, P; Massucchetti, C; Molinatti, GM | 1 |
Zaun, H | 1 |
Costa, C; De Pedrini, P; Suraci, C | 2 |
Fanjul, LF; Hsueh, AJ; Meidan, R; Ruiz de Galarreta, CM | 1 |
Hammerstein, J; Moltz, L; Schwartz, U | 1 |
Raj, SG; Talbert, LM | 1 |
Coney, P | 1 |
Ylöstalo, P | 1 |
Callan, AW; Montalto, J | 1 |
Bourguignon, JP; Kulin, HE | 1 |
Durmuşoğlu, F; Erenus, M; Gürbüz, O; Pekin, S; Yücelten, D | 1 |
Grunwald, K; Rabe, T; Runnebaum, B; Schlereth, G | 1 |
Shaw, JC | 1 |
Bártfai, G; Koloszár, S; Szöllösi, J | 1 |
Keleştimur, F; Sahin, Y | 2 |
Price, VH; Shapiro, J | 1 |
Sinclair, R; Young, R | 1 |
Brimer, C; Schuetz, EG; Schuetz, JD | 1 |
Sinclair, RD; Tran, D | 1 |
Rittmaster, RS | 1 |
Asscheman, H; Hage, JJ; Kanhai, RC; Mulder, JW | 1 |
Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
Holst, M; Ritzén, EM; Svechnikov, K | 1 |
Kelestimur, F | 1 |
Hannuksela, M | 1 |
Drapier-Faure, E; Faure, M | 1 |
Lumachi, F; Rondinone, R | 1 |
Kirim, S; Sert, M; Tetiker, T | 1 |
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
Bendtzen, K; Hansen, PR; Rieneck, K | 1 |
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA | 1 |
Haroun, M | 1 |
Lynde, CW | 1 |
Jolley, D; Sinclair, R; Wewerinke, M | 1 |
Al-Inany, H | 2 |
Inal, MM; Taner, CE; Yildirim, Y | 1 |
Conway, GS; Koulouri, O | 1 |
Pijl, H; van Zuuren, EJ | 1 |
Yildiz, BO | 1 |
Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
Scheinfeld, N | 1 |
Clarke, S; George, R; Thiboutot, D | 1 |
Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
Alacacioglu, A; Bilgir, O; Kebapcilar, AG; Kebapcilar, L; Kozaci, DL; Sari, I; Taner, CE; Yildiz, Y; Yuksel, A | 1 |
Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S | 1 |
Basso, SM; Lumachi, F | 1 |
Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
Dickson, GM | 1 |
Dixit, S; Fischer, G; Olsson, A | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
Bettoli, V; Virgili, A; Zauli, S | 1 |
Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
Ioannides, D; Lazaridou, E | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Chahal, DS; Hassoun, LA; Larsen, LN; Sivamani, RK | 1 |
Arnold, JD; Coleman, ME; Goldstein, DA; Sarkodie, EP | 1 |
Fung, R; Hellstern-Layefsky, M; Lega, I; Steele, L; Tastenhoye, C | 1 |
Defreyne, J; T'Sjoen, G | 1 |
Fung, R; Lega, I | 1 |
Chan, KJ; Jolly, D; Liang, JJ; Safer, JD | 1 |
Kyrgidis, A; Nikolakis, G; Zouboulis, CC | 1 |
Broux, E; Catteau-Jonard, S; Dewailly, D | 1 |
Burinkul, S; Panyakhamlerd, K; Suwan, A; Tuntiviriyapun, P; Wainipitapong, S | 1 |
33 review(s) available for spironolactone and cyproterone acetate
Article | Year |
---|---|
[Anti-androgen therapy in the female].
Topics: Androgen Antagonists; Androgens; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Humans; Spironolactone | 1990 |
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Puberty, Precocious; Skin Diseases; Spironolactone | 1988 |
[Available anti-androgens for treating skin hyperandrogenism].
Topics: Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Endocrine System Diseases; Female; Humans; Skin Diseases; Spironolactone | 1989 |
[Antiandrogens. Mechanisms and paradoxical effects].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Anilides; Cimetidine; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Nitriles; Spironolactone; Tosyl Compounds | 1989 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
[Hormonal aspects of acne].
Topics: Acne Vulgaris; Adolescent; Adrenal Cortex Hormones; Adult; Androgen Antagonists; Androgens; Child; Child, Preschool; Cyproterone; Cyproterone Acetate; Estrogens; Female; Humans; Infant; Infant, Newborn; Male; Pituitary Hormones; Progesterone; Sebum; Spironolactone | 1987 |
Female hirsutism: pathophysiological considerations and therapeutic implications.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Glands; Adrenocorticotropic Hormone; Androgen Antagonists; Androgens; Androstenedione; Biological Transport, Active; Blood Proteins; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Female; Hirsutism; Humans; Kinetics; Ovary; Sex Hormone-Binding Globulin; Skin; Spironolactone | 1984 |
Polycystic ovarian disease.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Chorionic Gonadotropin; Cimetidine; Clomiphene; Contraceptive Agents, Female; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone | 1984 |
Polycystic ovarian disease: current concepts of pathophysiology and therapy.
Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Glands; Androgen Antagonists; Androstenedione; Animals; Cimetidine; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone; Testosterone | 1984 |
Female androgenetic alopecia: an update.
Topics: Alopecia; Androgens; Cyproterone Acetate; Female; Humans; Minoxidil; Prognosis; Spironolactone | 1995 |
Antiandrogen therapy in dermatology.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Cimetidine; Contraceptives, Oral; Cyproterone Acetate; Finasteride; Flutamide; Humans; Ketoconazole; Skin Diseases; Spironolactone | 1996 |
Hair regrowth. Therapeutic agents.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone | 1998 |
Hirsutes. II: Treatment.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Contraceptives, Oral; Cosmetics; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Hair Removal; Hirsutism; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Prednisolone; Spironolactone | 1998 |
Understanding and managing common baldness.
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome | 1999 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
[Loss of hair].
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome | 2000 |
[Hormonal treatments of acne].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Estrogens; Glucocorticoids; Humans; Mineralocorticoid Receptor Antagonists; Patient Care Planning; Progestins; Spironolactone | 2003 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Hormonal therapy of acne.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Flutamide; Humans; Middle Aged; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
A systematic review of commonly used medical treatments for hirsutism in women.
Topics: Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Spironolactone; Thiazolidinediones; Treatment Outcome | 2008 |
[Hirsutism].
Topics: Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Female; Hirsutism; Humans; Obesity; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome; Weight Loss | 2007 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Hormonal therapy for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Female; Flutamide; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone | 2008 |
Anti-androgen treatments.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone | 2010 |
Medical Treatment of Hirsutism in Women
Topics: Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Estrogens; Female; Hair Removal; Hirsutism; Humans; Progestins; Spironolactone | 2010 |
Is hormonal treatment still an option in acne today?
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Flutamide; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Spironolactone | 2015 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
The use of hormonal agents in the treatment of acne.
Topics: Acne Vulgaris; Administration, Oral; Contraceptive Agents; Cortodoxone; Cyproterone Acetate; Dermatologic Agents; Female; Finasteride; Flutamide; Hormones; Humans; Male; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Propionates; Spironolactone; Treatment Outcome | 2016 |
Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data.
Topics: Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Finasteride; Hidradenitis Suppurativa; Humans; Metformin; Randomized Controlled Trials as Topic; Skin; Spironolactone; Treatment Outcome | 2019 |
19 trial(s) available for spironolactone and cyproterone acetate
Article | Year |
---|---|
Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Female; Hair; Hirsutism; Humans; Middle Aged; Prospective Studies; Spironolactone; Testosterone | 1991 |
Antiandrogens: clinical applications.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Female; Flutamide; Hirsutism; Humans; Male; Prostatic Neoplasms; Spironolactone | 1990 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
Antiandrogens and hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydroxyprogesterones; Prolactin; Spironolactone; Testosterone | 1987 |
Antiandrogens in the treatment of acne and hirsutism.
Topics: Acne Vulgaris; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Progestins; Spironolactone; Structure-Activity Relationship; Testosterone | 1983 |
Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Prospective Studies; Single-Blind Method; Spironolactone; Testosterone | 1996 |
[Ovulation induction with adjuvant antiandrogen treatment in Stein-Leventhal syndrome].
Topics: Adult; Androgen Antagonists; Anovulation; Cyproterone Acetate; Dexamethasone; Female; Humans; Hyperandrogenism; Infertility, Female; Mineralocorticoid Receptor Antagonists; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Spironolactone | 1996 |
Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies; Spironolactone; Treatment Outcome | 1998 |
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Spironolactone; Testosterone | 2003 |
Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone | 2003 |
Treatment of female pattern hair loss with oral antiandrogens.
Topics: Adolescent; Adult; Aged; Alopecia; Androgen Antagonists; Biopsy; Child; Cyproterone Acetate; Female; Hair; Humans; Middle Aged; Multivariate Analysis; Photography; Severity of Illness Index; Single-Blind Method; Spironolactone; Treatment Outcome | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
Topics: Adolescent; Adult; CD40 Antigens; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2010 |
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Female; Humans; Spironolactone; Testosterone; Transgender Persons; Transsexualism | 2021 |
39 other study(ies) available for spironolactone and cyproterone acetate
Article | Year |
---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Therapeutic alternatives for the hirsute woman.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Retrospective Studies; Spironolactone; Trinidad and Tobago | 1992 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
The treatment of hirsutism: experience with cyproterone acetate and spironolactone.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Spironolactone; Time Factors | 1985 |
[The concept of the causal therapy of hirsutism].
Topics: Cimetidine; Cyproterone; Cyproterone Acetate; Hirsutism; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Androgen; Spironolactone | 1986 |
[Therapeutic use of androgens and antiandrogens in the female].
Topics: Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Female; Humans; Spironolactone | 1987 |
Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
Topics: Androgen Antagonists; Body Height; Bone Development; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follow-Up Studies; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Function Tests; Spironolactone; Testolactone | 1987 |
Antiandrogenic effects of topically applied spironolactone on the hamster flank organ.
Topics: Administration, Topical; Androgen Antagonists; Animals; Back; Castration; Cricetinae; Cyproterone; Cyproterone Acetate; Male; Mesocricetus; Models, Biological; Organ Size; Sebaceous Glands; Seminal Vesicles; Spironolactone | 1985 |
A comparative study of Aldactone and Diane in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin; Spironolactone | 1987 |
[Indications and limits of anti-androgen therapy].
Topics: Acne Vulgaris; Alopecia; Androgen Antagonists; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Therapy, Combination; Female; Hirsutism; Humans; Male; Skin Diseases; Spironolactone | 1984 |
[Therapy of female hirsutism: current status and new findings].
Topics: Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Bromocriptine; Cimetidine; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Progesterone Congeners; Spironolactone; Thyronines; Time Factors | 1983 |
[Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Drug Evaluation; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone; Time Factors | 1983 |
Regulation of 3 beta-hydroxysteroid dehydrogenase activity by human chorionic gonadotropin, androgens, and anti-androgens in cultured testicular cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Androgen Antagonists; Androgens; Animals; Cells, Cultured; Chorionic Gonadotropin; Cyproterone; Cyproterone Acetate; Estrenes; Humans; Male; Metribolone; Rats; Spironolactone; Testis; Testosterone | 1983 |
[Diagnosis and treatment of hirsutism].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Spironolactone | 1984 |
True or central precocious puberty.
Topics: Cyproterone Acetate; Female; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Medroxyprogesterone Acetate; Puberty, Precocious; Spironolactone; Testolactone | 1994 |
[Serum hormones before and during therapy with cyproterone acetate and spironolactone in patients with androgenization].
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonadal Steroid Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 1994 |
Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element.
Topics: Androgen Antagonists; Animals; Aryl Hydrocarbon Hydroxylases; Cell Line; Cell Nucleus; Cyproterone Acetate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Environmental Pollutants; Enzyme Activation; Mice; Mineralocorticoid Receptor Antagonists; Pregnane X Receptor; Pregnenolone; Promoter Regions, Genetic; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Response Elements; Spironolactone; Swine; Transcription, Genetic; Transfection; Xenobiotics | 1998 |
Augmentation mammaplasty in male-to-female transsexuals.
Topics: Adult; Androgen Antagonists; Breast; Breast Implantation; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Male; Mammaplasty; Middle Aged; Mineralocorticoid Receptor Antagonists; Spironolactone; Transsexualism | 1999 |
Androgen and estrogen stimulation of ornithine decarboxylase activity in mouse kidney.
Topics: Androgen Antagonists; Animals; Cyproterone Acetate; Dichlorodiphenyl Dichloroethylene; Dihydrotestosterone; Estradiol; Female; Flutamide; Kidney; Mice; Mice, Inbred CBA; Ornithine Decarboxylase; Oxazoles; Spironolactone; Testosterone | 2000 |
Diane 35 and spironolactone combination in the treatment of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone | 2001 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Topics: Aldosterone; Canrenoic Acid; Cells, Cultured; Cyproterone Acetate; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Phytohemagglutinins; Pregnadienes; RNA, Messenger; Spironolactone; Transcription, Genetic | 2004 |
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone | 2005 |
Hormonal approach to the treatment of acne a Canadian perspective.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Canada; Child; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Humans; Middle Aged; Spironolactone | 2004 |
Assessment, diagnosis and treatment of a patient with hirsutism.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Ultrasonography | 2008 |
Menopause management: how you can do better.
Topics: Acupuncture Therapy; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Topical; Affect; Age Factors; Androgen Antagonists; Androgens; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atrophic Vaginitis; Azabicyclo Compounds; Bupropion; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Dyspareunia; Estrogens; Eszopiclone; Exercise; Female; Hair; Hormone Replacement Therapy; Hot Flashes; Humans; Hypnotics and Sedatives; Libido; Life Style; Lubricants; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Minoxidil; Phytotherapy; Piperazines; Sleep Initiation and Maintenance Disorders; Spironolactone; Testosterone | 2012 |
A case series of 11 patients with hormone-responsive sebaceous adenitis of the labia minora.
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Middle Aged; Sebaceous Gland Diseases; Spironolactone; Tetracyclines; Vulvar Diseases | 2014 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
Topics: Administration, Oral; Adult; Androgen Antagonists; Cyproterone Acetate; District of Columbia; Estradiol; Estrogens; Europe; Female; Gender Identity; Gonadal Steroid Hormones; Humans; Incidence; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Risk Factors; Spironolactone; Transgender Persons; Transsexualism; Venous Thrombosis | 2016 |
Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
Topics: Adult; Androgen Antagonists; Canada; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Female; Humans; Lipoproteins, HDL; Male; Prolactin; Retrospective Studies; Sex Reassignment Surgery; Spironolactone; Transgender Persons; Transsexualism | 2016 |
Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
Response to "Letter to the Editor Concerning the Paper by Fung et al titled 'Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
Topics: Adult; Aged; Cross-Sectional Studies; Cyproterone Acetate; Estrogens; Female; Humans; Male; Middle Aged; Sex Reassignment Procedures; Spironolactone; Testosterone; Transgender Persons; Transsexualism; United States; Young Adult | 2018 |
[Spironolactone as a relay for cyproterone acetate in hyperandrogenic women].
Topics: Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Female; France; Humans; Hyperandrogenism; Patient Satisfaction; Retrospective Studies; Spironolactone; Testosterone | 2020 |